163 related articles for article (PubMed ID: 20601655)
1. Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease.
Gono T; Kawaguchi Y; Sugiura T; Ichida H; Takagi K; Katsumata Y; Hanaoka M; Okamoto Y; Ota Y; Yamanaka H
Rheumatology (Oxford); 2010 Oct; 49(10):1878-81. PubMed ID: 20601655
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I
J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
[TBL] [Abstract][Full Text] [Related]
3. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H
J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
[TBL] [Abstract][Full Text] [Related]
4. Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis.
Le Goff B; Chérin P; Cantagrel A; Gayraud M; Hachulla E; Laborde F; Papo T; Sibilia J; Zabraniecki L; Ravaud P; Puéchal X
Arthritis Rheum; 2009 Jan; 61(1):108-18. PubMed ID: 19116970
[TBL] [Abstract][Full Text] [Related]
5. Biologics in polymyositis and dermatomyositis-associated interstitial lung disease.
Sun Y; He Y; Liu Y; Shi G
Curr Pharm Biotechnol; 2014; 15(6):521-4. PubMed ID: 25213360
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study.
Ji SY; Zeng FQ; Guo Q; Tan GZ; Tang HF; Luo YJ; Tang ZQ; Han YF
Chin Med J (Engl); 2010 Mar; 123(5):517-22. PubMed ID: 20367973
[TBL] [Abstract][Full Text] [Related]
7. Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis.
Gono T; Kawaguchi Y; Hara M; Masuda I; Katsumata Y; Shinozaki M; Ota Y; Ozeki E; Yamanaka H
Rheumatology (Oxford); 2010 Jul; 49(7):1354-60. PubMed ID: 20385617
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?
Maeda K; Kimura R; Komuta K; Igarashi T
Scand J Rheumatol; 1997; 26(1):24-9. PubMed ID: 9057798
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis.
Kurita T; Yasuda S; Oba K; Odani T; Kono M; Otomo K; Fujieda Y; Oku K; Bohgaki T; Amengual O; Horita T; Atsumi T
Rheumatology (Oxford); 2015 Jan; 54(1):39-44. PubMed ID: 24764266
[TBL] [Abstract][Full Text] [Related]
10. Predicting factors of interstitial lung disease in dermatomyositis and polymyositis.
Chen YJ; Wu CY; Shen JL
Acta Derm Venereol; 2007; 87(1):33-8. PubMed ID: 17225013
[TBL] [Abstract][Full Text] [Related]
11. [Prognosis of interstitial pneumonitis (IP) in polymyositis (PM)/dermatomyositis (DM)].
Saeki T; Suzuki E; Watanabe T; Saito Y; Itou S; Honma T; Sato T; Nakano M; Arakawa M
Ryumachi; 1994 Feb; 34(1):16-21. PubMed ID: 8146722
[TBL] [Abstract][Full Text] [Related]
12. [The predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis/dermatomyositis].
Wang PZ; Guan JL; Han XH
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):417-20. PubMed ID: 19031800
[TBL] [Abstract][Full Text] [Related]
13. [Coping with pathological changes in heart and lung in collagen diseases--dermatomyositis and interstitial pneumonia].
Nawata Y
Nihon Naika Gakkai Zasshi; 1996 Nov; 85(11):1850-4. PubMed ID: 9019505
[No Abstract] [Full Text] [Related]
14. Polymyositis-dermatomyositis-associated interstitial lung disease.
Douglas WW; Tazelaar HD; Hartman TE; Hartman RP; Decker PA; Schroeder DR; Ryu JH
Am J Respir Crit Care Med; 2001 Oct; 164(7):1182-5. PubMed ID: 11673206
[TBL] [Abstract][Full Text] [Related]
15. Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants.
Takada K; Nagasaka K; Miyasaka N
Autoimmunity; 2005 Aug; 38(5):383-92. PubMed ID: 16227154
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis].
Tong SQ; Shi XH; Su JM; Zhao Y; Zhang FC
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):624-7. PubMed ID: 16681909
[TBL] [Abstract][Full Text] [Related]
17. [Outcome in patients with interstitial lung disease and polymyositis-dermatomyositis--a subgroup with poor prognosis].
Takizawa H; Suzuki N; Yanagawa T; Okazaki H; Satoh M; Akiyama N; Kohyama T; Kawasaki S; Ito K; Oka T
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Oct; 34(10):1093-7. PubMed ID: 8953902
[TBL] [Abstract][Full Text] [Related]
18. Interstitial lung disease due to polymyositis or dermatomyositis: effect of a 6-month course of i.v. pulse cyclophosphamide.
Meyer O; Hayem G; Palazzo E; Crestani B; Debray MP; Ballard M
Clin Exp Rheumatol; 2005; 23(5):724. PubMed ID: 16173257
[No Abstract] [Full Text] [Related]
19. Fatal acute interstitial pneumonitis complicating polymyositis in a 41-year-old man.
Aoun NY; Velez E; Aggarwal A; Hayes GB; Kenney LA
Respir Care; 2004 Dec; 49(12):1515-21. PubMed ID: 15571643
[TBL] [Abstract][Full Text] [Related]
20. Role of endothelial damage in the pathogenesis of interstitial pneumonitis in patients with polymyositis and dermatomyositis.
Funauchi M; Shimadsu H; Tamaki C; Yamagata T; Nozaki Y; Sugiyama M; Ikoma S; Kinoshita K
J Rheumatol; 2006 May; 33(5):903-6. PubMed ID: 16652421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
